|Articles|February 15, 2022
Supplements and Featured Publications
- Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Advertisement
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that has no established cure and is frequently fatal within 2 to 5 years as patients experience a rapid functional decline in their abilities to move, talk, swallow, and breathe. Current treatment options remain limited, but there is a pipeline of late-stage therapeutic options that could expand the treatment options for patients with ALS.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
5

